Dr. Jamie Dee Lavender, MD

Dr. Lavender practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Lavender's NPI, 1811255276, was assigned on April 24, 2012. Dr. Lavender graduated from University of California San Diego School of Medicine in 2010. Dr. Lavender's California license number on file is A119417.

Dr. Lavender's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Lavender's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Lavender is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Lavender to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lavender practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lavender's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lavender is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lavender has a license on file in California.

Dmand AI lists acid reflux, alzheimer's disease, arterial blot clot /embolism, asthma, atrial fibrillation and flutter, bladder disease, bursitis and chronic diabetes among the conditions Dr. Lavender treats.

CMS data shows 500 Medicare services from Dr. Lavender across 9 procedure codes in 2024, for 165 Medicare patients. Medicare paid $34,654 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Lavender in 2024. The largest group is 65 to 74, with 84 patients. 71% of them have high cholesterol, and 62% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lavender's median patient age at 58, with 79% women.

In 2024, Dr. Lavender wrote 4,982 Medicare Part D claims for 508 patients. 87% of them were for generic drugs. CMS names the drug for 4,343 of them, across 92 drugs with 11 or more claims each, at $366,656 in total drug cost. In 2023, CMS named 4,427 claims across 99 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lavender for performance year 2024, reported as part of a group. Dr. Lavender accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lavender as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 21 general payments to Dr. Lavender from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $877.

Dr. Lavender graduated from University of California San Diego School of Medicine in 2010.

Dr. Lavender is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.